Seema Bhat
Clinical trials sponsored by Seema Bhat, explained in plain language.
-
New hope for CLL patients: a drug that may spare the heart
Disease control Recruiting nowThis study tests whether acalabrutinib, a drug similar to ibrutinib, is safer for the heart in people with chronic lymphocytic leukemia (CLL). Many patients on ibrutinib develop heart side effects and have to stop treatment. Researchers will give acalabrutinib to 61 adults with C…
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Yearly shots could shield CLL patients from deadly infections
Prevention Recruiting nowThis study tests whether giving yearly pneumococcal vaccines to people with chronic lymphocytic leukemia (CLL) provides better protection than the standard vaccine given every 5 years. About 80 adults with untreated CLL will receive either the yearly schedule or the standard sche…
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC